Article
Cytomegalovirus protease targeted prodrug development.
Molecular pharmaceutics - 1 Apr 2013
Sabit Hairat, Dahan Arik, Sun Jing, Provoda Chester J, Lee Kyung-Dall, Hilfinger John H, Amidon Gordon L
Abstract excerpt
Human cytomegalovirus (HCMV) is a prevalent virus that infects up to 90% of the population. The goal of this research is to determine if small molecular prodrug substrates can be developed for a specific HCMV encoded protease and thus achieve site-specific activation. HCMV encodes a 256 amino acid serine protease that is responsible for capsid assembly, an essential process for herpes virus production. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
